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Background: Low efficiency of Somatic Cell Nuclear Transfer (NT) has been widely addressed with high incidence
of placental abnormalities due to genetic and epigenetic modifications. MiRNAs are shown to be major regulators
of such modifications. The present study has been carried out to identify the expression patterns of 377 miRNAs,
their functional associations and mechanism of regulation in bovine placentas derived from artificial insemination
(AI), in vitro production (IVP) and NT pregnancies.
Results: This study reveals a massive deregulation of miRNAs as chromosomal cluster or miRNA families without
sex-linkage in NT and in-vitro derived IVP placentas. Cell specific localization miRNAs in blastocysts and expression
profiling of embryos and placentas at different developmental stages identified that the major deregulation of miRNAs
exhibited in placentas at day 50 of pregnancies is found to be less dependent on global DNA methylation, rather than
on aberrant miRNA biogenesis molecules. Among them, aberrant AGO2 expression due to hypermethylation of its
promoter was evident. Along with other factors, aberrant AGO2 expression was observed to be associated with
multiple defects in trophoblast differentiation through deregulation of miRNAs mediated mechanisms.
Conclusion: These aberrant miRNA activities might be associated with genetic and epigenetic modifications in
abnormal placentogenesis due to maldifferentiation of early trophoblast cell lineage in NT and IVP pregnancies.
This study provides the first insight into genome wide miRNA expression, their role in regulation of trophoblast
differentiation as well as abnormal placental development in Somatic Cell Nuclear Transfer pregnancies to pave the
way to improve the efficiency of cloning by nuclear transfer.
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Animal cloning is a break-through technology with emer-
ging potential applications in agricultural and biomedical
research. However, the technology is hindered by very low
rates of healthy live births attributed to high incidences of
placental abnormalities leading to embryonic losses [1,2].
The major sources of these abnormalities is thought to be
genetic and epigenetic modifications occurred due to* Correspondence: tesfaye@itw.uni-bonn.de
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reproduction in any medium, provided the orimproper reprogramming of donor cells after nuclear
transfer leading to post-implantation lethality or abnor-
mality [3-5]. Key mechanisms underlying this aberration
are DNA methylation, histone remodeling and telomere
maintenance, which are involved in the control of gene
expression, X chromosome inactivation and genomic im-
printing [6,7]. However, all these mechanisms are not con-
tributing equally to the embryonic and extra-embryonic
lineage [8,9]. Specially, genomic imprinting was found to
be less or not dependent on DNA methylation for its
somatic maintenance in placentas than in the embryos.
Whereas, placenta-specific imprinting has been shown tol Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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well as regulation by non-coding RNAs [7,10]. Among
the non-coding RNAs, a recently discovered class of
small RNAs, namely miRNAs appeared as important
regulators of gene expression at the transcriptional or
post-transcriptional level. They are found to play im-
portant roles including but not restricted to cell prolif-
eration, apoptosis, diseases and differentiation during
mammalian development [11,12]. Moreover, they are
targeted by epigenetic modifications in which some
imprinted miRNAs were found to undergo subsequent
epigenetic reprogramming in mouse embryos [13,14].
However, the patterns of miRNAs expression contributing
to the widely addressed placental abnormalities along with
genetic and epigenetic modifications in the IVP or NT
placentas are yet to be discovered. Therefore, the main ob-
jective of this study was to investigate the expression of
regulatory non-coding miRNAs in bovine day-50 placen-
tas derived from pregnancies established after AI or trans-
fer of IVP and SCNT derived bovine embryos. For this,
the expression of 377 miRNAs was investigated using a
quantitative real time PCR array technology in placentas
of these three origins as well as donor fibroblast cells used
for SCNT. Furthermore, selected differentially expressed
miRNAs were analyzed for their expression in expanded
blastocysts, day-16 elongated embryos as well as placentas
at day 50 and day 225 of pregnancies from SCNT, IVP
and AI embryos. Finally, methylation status and activities
of miRNAs processing molecules were also studied in
those samples.
Results
Differential miRNA expression in day-50 placentas of
different sources of pregnancy
The expressions of 377 miRNAs were compared between
placentas at day 50 of pregnancy derived from NT (n = 3),
IVP (n = 3) and AI (n = 3) embryos (Figure 1A). Among
the 377 miRNAs, 278 miRNAs were found to be down-
regulated in NT placentas with 2 or more fold change
with P-value ≤ 0.05, while only 5 miRNAs (miR-527, miR-
608, miR-637, miR-649 and miR-938) were found to be
upregulated in the same placenta group compared to the
placentas of AI pregnancies. Out of all downregulated
miRNAs, 116 were unique to the NT placentas compared
either to AI or IVP placentas. On the other hand, a total
of 191 miRNAs were found to be differentially expressed
in the NT placentas compared to their IVP counterparts.
Among these, only 21 miRNAs were upregulated and the
remaining 170 miRNAs were found to be downregulated.
Comparison of IVP and AI derived placentas revealed dif-
ferential expression of 238 miRNAs, of which 8 miRNAs
(miR-122, miR-302a, miR-302b, miR-302c, miR-525-3p,
miR-526b, miR-590-3p and miR-944) and 230 miRNA
were found to be up and down regulated, respectively. Ofthese downregulated 230 miRNAs, 215 were also found to
be down regulated in NT placentas compared to IVP de-
rived ones.Comparative expression of miRNA between donor cells
and NT day-50 placentas
To investigate the source-of-origin specific miRNA ex-
pression pattern, the profiles of same 377 miRNAs have
been compared between NT placentas and the fibro-
blast donor cells. A total of 209 miRNAs were found to
be differentially expressed between these two groups by
fold change 2 or more with P value ≤0.05. Among these,
185 and 24 miRNAs were found to be up and down
regulated in NT placentas compared to fibroblast donor
cells, respectively.Chromosomal allocation of deregulated miRNAs in NT
and IVP placentas
The chromosomal location of deregulated miRNAs and
features of genomic regions were retrieved from miR-
Base v 14 and ENSEMBL genome browser (Btau_4.0 as-
sembly, Ensembl release 63) [15]. Deregulated miRNAs
in NT and IVP placentas were found to exhibit similar
patterns and localizations on the chromosomes as poly-
cistronic clusters. One of such genomic region has been
identified in bovine chromosome 21 (btau21:66000000–
66044000, 44 kb) harboring at least 3 clusters of miR-
NAs comprising more than 38 miRNAs (Figure 2A).
Most of these clustered miRNAs were found to be
downregulated in NT and some in IVP placentas com-
pared to that of AI. Genomic sequence of these cluster
were found to be devoid of any protein coding gene but
enriched in several genomic variable elements including
different types of transposone elements, (type I LINE,
type I SINE, type II), tandem repeats (TRF), long ter-
minal repeats (LTRs) and numerous SNPs (Figure 2A).
However, most of these elements and SNPs were found
to be residing out side the mature miRNA or precursor
sequences. Moreover, family wise expression pattern of
miRNAs was evident for differentially expressed miR-
NAs (Figure 1C). The top 43 miRNAs, which are down-
regulated in NT and IVP day-50 placentas, belong to 9
distinct miRNA families. Similarly, miRNAs sharing
similar sequence (denoted and distinguish by a, b, c,
etc.) were also found to be deregulated in the placentas
in a similar manner. Interestingly, most of the miRNAs
located on the bovine X-chromosome, were found not
to be differentially regulated between contrasting types
of placentas under investigation (Figure 1B). However,
among the x-linked miRNAs, miR-188, miR-222, miR-504
and miR-505 were found to be downregulated in NT and
IVP placentas compared to their AI counterparts.
Figure 1 (See legend on next page.)
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Figure 1 Number and types of differentially expressed miRNAs in different sources of placenta together with their relation to global
methylation status and expression of miRNA processing genes. (A) Venn diagram of the distribution and the number of differential miRNA
expression between and specific to different types of day-50 placentas. Each circle represents the number of differentially expressed miRNAs
between two placenta types out of 377 analyzed miRNAs. For example, NT vs. AI represents the number of differentially regulated miRNAs
(↓ denotes down regulation and ↑ denotes upregulation) in the NT placentas compared to that of AI. (B) Hierarchical cluster (log2 fold change)
of NT, IVP and AI day-50 placentas compared to each other and characterization of differentially expressed X-linked miRNAs. (C) Family wise
differential expression of miRNAs in different sources of day-50 placentas. Log2 fold change of 43 miRNAs belong to 9 miRNA families which were
deregulated in different sources of placenta were plotted to visualize the family wise expression differences in the placentas of different sources
of pregnancies. (D) Global DNA methylation (%) in day-16 elongated embryos and day-50 placenta of different sources of pregnancy. (E) Signifi-
cant differential expression of 10 miRNA processing genes in different sources of placentas and donor fibroblast cells.
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of NT, IVP and AI origin
To identify spatial difference in miRNAs expression at
earliest stage of development and existence of aberrant
expression of miRNA between trophectoderms derived
from different sources of blastocysts, candidate miRNAs
were localized through whole mount in-situ hybridization.
Among these candidate miRNAs, miR-24, and miR-299
were found to be intensively localized to the trophecto-
derm, while miR-302b to inner cell mass considering
in-vivo (AI) derived expanded blastocyst (Figure 3). Ex-
pression of trophectoderm specific miRNAs was lower in
NT blastocysts compared to AI counterparts. Two other
miRNAs (miR-127 and miR-431), which are residing in
the large imprinted chromosomal region were found to be
similarly expressed in both the inner cell mass and the
trophectoderm of AI blastocysts, while being aberrantly
expressed in NT blastocysts. In NT blastocysts, miR-
127 is almost depleted from the trophectoderm with
no change in the inner cell mass. Results of in situ
hybridization of miRNAs revealed aberrant miRNAs ex-
pression in the trophectoderm and inner cell mass of
NT expanded blastocyst compared to their AI counter-
parts. Negative control probes have been used for all
groups during hybridization and they were found to be
negative (data not shown).
Temporal expression pattern of candidate miRNAs in
different sources of placenta
Expression profiling of candidate miRNAs considering
in vivo, in vitro or NT originated day-7 blastocyst,
expanded blastocyst, day-16 elongated embryos, day-50
placentas and day-225 placentomes revealed that the
major deregulations were likely to happen in the NT
placentas at day-50 of the pregnancy when compared to
the AI placentas (Figure 2B-E). However, the extent of
this deregulation in IVP placentas at day 50 was lower
and showed very less difference compared to the placen-
tas of AI at day 50 of pregnancy. Moreover, this deregu-
lation of miRNAs found to be started as early as first
cell lineage differentiation in nuclear transfer derived
embryos and progressing to the later stage. This is moreprofound in the day-50 placentas, at which time point,
most aberrant miRNAs expression is evident concomi-
tant to redifferentiation for placentogenesis.
DNA methylation status in different sources of elongated
embryos and placentas
Global DNA methylation pattern has been investigated
in elongated day-16 embryos and day-50 placentas de-
rived from NT, IVP and AI pregnancies. Results revealed
a global hypomethylation of DNA in all three groups
(NT, IVP and AI) across these two stages of develop-
ment (Day-16 elongated embryos and day-50 placentas)
(Figure 1D). In contrast, there was no significant differ-
ence in global DNA methylation pattern comparing elon-
gated day-16 embryos as well as day-50 placentas between
NT, IVP and AI pregnancies.
Expression pattern of miRNAs processing genes in IVP
and NT placentas
Expression profiling of miRNA processing machinery
genes in day-50 placentas from NT and IVP pregnancies
compared to that of AI was performed (Figure 1E). Re-
sults revealed that all genes under study except AGO2
were transcriptionally reprogrammed in NT compared
to AI placentas. However, miRNA processing genes in-
cluding AGO2, AGO3, GEMIN7, and XPO4 were found
to be deregulated in IVP placentas compared to their AI
counterparts. AGO2 (EIF2C2: eukaryotic transcription
initiation factor 2C2) mRNA and protein (Figure 4A)
were found to be down regulated in both NT and IVP
day-50 placentas compared to that of AI.
Status of AGO2 promoter methylation in
different placentas
The DNA methylation status of 18 CpG sites in the
CpG island of AGO2 promoter region were analyzed
and results evidenced a significantly higher methylation
status of the AGO2 promoter in NT placentas (89 ±
9.7%) compared to AI placentas (72 ± 2.7%) (Figure 2F).
In IVP placentas, the promoter was methylated by 76 ±
7.52%. Moreover, two CpG sites located at 757 bp and
789 bp downstream of the transcription start site,
Figure 2 Localization of miRNA in the chromosome as polycistronic cluster and expression of trophectoderm/placenta specific/
imprinted miRNAs in different stages of embryos and placentas from different sources of pregnancies. A: Genomic region (44 kb) of
bovine chromosome 21 harboring at least 3 big clusters of miRNAs which are down regulated in day-50 NT and IVP placentas compared
to that of AI. Text in blue above the black line (forward genomic strand) represents the residing miRNAs; number in pink represents range
and scale of the region in kilo bases (kb), number in black starting with rs- denotes dbSNPs, others are different types of transposone (red
or orange) namely type I line/SINE, type II, tandem repeats (trf) and pseudo transfer RNA (tRNA). B-E: Expression pattern (in fold change) of
the candidate trophectoderm/placenta specific (B) and imprinted miRNAs (C) in blastocyst, expanded blastocyst, day-16 elongated embryo,
day-50 placenta and day-225 placentome derived from IVP pregnancies compared to that from AI. Expression pattern (in fold change) of
the candidate trophectoderm/placenta specific (D) and imprinted miRNAs (E) in blastocyst, expanded blastocyst, day-16 elongated embryo,
day-50 placenta and day-225 placentome derived from NT pregnancies compared to that of AI pregnancies. F: Methylation status of AGO2
promoter region in the day-50 placentas from different sources of pregnancies. Note the degree of methylation in NT placentas significantly
differed from AI placentas.
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increased DNA methylation (100% for both sites) in NT
placentas compared to AI placentas (57% and 71%,
respectively).Functional analysis of AGO2 in differentiation of
Trophoblastic stem cells (TBSs)
To substantiate, whether global deregulation of miRNAs
is associated with defective differentiation of trophoblast
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model, TBSs were derived and used to induce knockdown
of AGO2mRNA using sequence specific siRNA. The TBSs
were derived from in vitro produced bovine blastocysts
which were found to form a monolayer sheet of polygonal
cells on type I collagen coated flasks (Figure 5C). Spherical
multicellular vesicles of 100 to 900 μm in diameter were
found to be continuously formed through accumulation
of fluid under the cell sheet (Figure 5E). These vesicles,
which resemble the trophectoderm of blastocysts, were
used for subculture and subsequent knock-down experi-
ments. The epithelial phenotype of TBSs was validated by
the expression of IFN-tau, which is a marker of trophecto-
derm cells in ruminants (Figure 5J) (Martal et al. 1998;
Roberts et al. 1999). The procedure of TBSs culture for
in vitro differentiation in this experiment was modified
from Nakano et al., (2002) and results revealed not only
the differentiation of TBSs into binucleate cells (17% of
total cell population) but also into distinct types of differ-
ent mononucleated cells namely trophoblast giant cells
(15%), spongiotrophoblast cells (8%), glycogen cells (10%),
and syncytial trophoblast cells (8%) (Figures 6 and 4E).Figure 3 Whole-mount in situ hybridization of miRNAs in in vivo, in v
represents nuclear stain by DAPI. About half of the blastocyst comprising a
trophectoderm has been visualized in the upper image (a) in each group a
laser scanning confocal microscope and projected in three dimensions (3D
3D transverse region of upper and same blastocyst to visualize inner cell m
indicates the region of inner cell mass.Differentiated TBSs were characterized by lower to almost
no expression of CDX2 and higher expression of PAG2 by
RT-PCR (Figure 5J).
Effect of AGO2 knock down on in vitro differentiation
of TBSs
Induced down regulation of miRNAs during in vitro TBS
cell differentiation was achieved through knock down of
AGO2 by siRNA technology. Specificity of siRNA medi-
ated AGO2 knock-down was confirmed by significant re-
duction of the corresponding mRNA by approximately
60% (Figure 4B) and resulted in reduced protein expression
for the same gene as demonstrated by western blotting
(Figure 4C) as well as immunocytochemistry (Figure 6)
compared to the controls. Quantitative real time PCR was
used to analyze changes with respect to expression of some
candidate trophectoderm/placenta specific and imprinted
miRNAs, which were found to be downregulated after
AGO2 knockdown (Figure 4D). Expression of TBSs cell
differentiation and placental cell markers (CDX2, IFN-
tau and PAG2) suggested that AGO2-deficient cells
exhibited differentiation but showed several markeditro and NT expanded blastocysts. MiRNAs are stained red and blue
pproximately middle region of the inner cell mass and corresponding
s obtained by scanning the blastocyst at every 2 μm interval using
). Similarly lower image (b) for every group of embryos represents a
ass and trophectoderm clearly. Scale bar represents 50 μm and ‘i’
Figure 4 Expression of AGO2 mRNA, protein and effect of knocking down of AGO2 mRNA in the regulation of miRNAs expression and
trophoblastic stem cell differentiation. A: Expression of AGO2 protein in the day-50 placentas from AI, NT and IVP derived pregnancies (A).
Expression of AGO2 mRNAs (B) and protein (C) 48 hours after transfection of AGO2 siRNA (siAGO2), nontransfected control (None) and transfec-
tion of nonspecific scrambled siRNAs (siSCR) in the TBSs during their differentiation in vitro. D: Expression of selected candidate miRNAs in three
groups of treated TBSs (siAGO2, none and siSCR). Images on the expression of AGO2 and the level of alkaline phosphatase activity (APA) in the
same three groups of cells (E).
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trol cells (Figures 5J, 4E and 6). AGO2-deficient cells were
characterized by reduction (50%) of primary trophoblastic
giant cells as well as a significant reduction of their diffe-
rentiation into secondary cells (especially binuclear cells)
compared to control cells (32% vs. 69%; P < 0.05). Overall
endopolyploidy level, which is determined by the ave-
rage number of DAPI stained blue nucleus per cells
was found to be significantly reduced (28%) in AGO2knocked down cells. Inline with that, a reduced average
size of nuclei was observed in the transfected cell. A
trophoblast cell was considered apoptotic when showing
fragmented nuclei (with blue channel for DAPI) which
were significantly higher (42%) in AGO2-siRNA transfected
cells compared to non-transfected groups (12%). Likewise,
a remarkable reduction in cumulative alkaline phosphatase
activity (red signal) in the AGO2-siRNAs transfected cells
was observed (Figure 6).
Figure 5 Derivation, culture, validation and knocking down of AGO2 during differentiation of trophoblastic stem cells (TBSs). Culture of
blastocyst at day 12 (A), derivation of TBSs at day 14 of culture (B), Fully grown TBSs (C and F), TBSs plated for subculture (D), developing trophoblastic
vesicles (VSC) (E), differentiated TBSs into distinctive placental cells (G), nontransfected differentiated TBSs (H) and differentiated TBSs transfected with
AGO2 siRNA (I). J: Expression of Homeobox protein CDX-2, Interferon tau-(ifn-tau), pregnancy-associated glycoproteins 2-PAG2 and Glyceraldehyde 3-phosphate
dehydrogenase-GAPDH mRNAs (as control) in TBSs (TB), nontransfected differentiated TBSs (DTBN) and differentiated TBSs transfected with AGO2 siRNA
(DTBSi). Blue arrow indicates binucleate cells and green arrow shows trophoblastic giant cells.
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Differential regulation of miRNAs in day-50 NT and
IVP placentas
The aberrant genetic or epigenetic modifications in the
NT placentas due to errors in nuclear reprogramming
have been evidenced by aberrant non-coding RNA expres-
sion, imprinting problems, changes in DNA methylation
and histone/chromatin modifications [6,7,10]. Among the
non-coding RNAs, miRNAs were found to be aberrantly
reprogrammed in cloned mouse blastocyst [13] and bovine
day-17 elongated embryos [16]. In the present study a large
number of miRNAs were found to be transcriptionally not
reprogrammed correctly in the NT (68% miRNA) and IVP
(36% miRNA) derived placentas. Relative expression ana-
lysis revealed a massive down regulation of miRNAs in
day-50 NT and IVP placentas compared to the day-50 pla-
centas from AI pregnancies. This difference could be due
to the cumulative effects of somatic cell nuclear transfer
and in vitro culture of the resulting embryos. At least 62%
of the miRNA studied in day-50 NT placentas were differ-
entially expressed compared to IVP placentas, where 90%
of them were found to be downregulated. Overall 36% of
the 377 miRNAs studied were differentially regulated be-
tween IVP and AI placentas, of which about 96% weredownregulated in IVP placentas. These massive deregula-
tions could be entailed to the reported radically altered
gene expression in cloned placenta [17,18] associated to
poor placentome development in NT pregnancies in the
first trimester leading to subsequent pregnancy loss.
Reprogramming errors in NT or IVP derived embryos
have been postulated to happen as a multi-step process
and the effect could vary depending on the stage of devel-
opment [19]. It has been suggested that the commonly
observed low developmental efficiency of NT embryos
may not be largely due to nuclear reprogramming during
early embryo development but potentially caused by ab-
normal gene reprogramming during postimplantation
feto-placental development [20]. While, NT blastocyst
more closely resemble the in vivo derived ones com-
pared to in vitro fertilized embryos in terms of global
gene expression [20], trophoblast lineage was found to
be significantly affected by reprogramming errors aris-
ing from epigenetic modifications during post blastocyst
stage [19]. The results of the present study showed that
the major deregulation of miRNAs in NT placentas to be
most profound at day 50 of pregnancy. Moreover, differ-
ences in their expression are also evident and advancing
to expanded blastocyst and embryo elongation stage. In
Figure 6 Effect of knocking down of AGO2 mRNA in the regulation of trophoblastic stem cell differentiation. Expression of AGO2 protein
(green) 48 hours after transfection of AGO2 siRNA (siAGO2) and nontransfected control (None) in the TBSs during their differentiation in vitro.
Trophoblastic giant cells, Glycogen cells and Spongiotrophoblast cells are indicated by red, blue and green arrowhead. White arrow and red circle
indicates binucleate cells and endopolyploidy level identified by the blue nuclear stain (DAPI) in the images including inset. Scale bar: 100 μm
(50 μm in the right column).
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be aberrantly expressed in the NT and IVP expanded blas-
tocysts compared to that of AI, while inner cell mass
specific miRNAs were less or not aberrantly expressed in
either NT or IVP expanded blastocysts compared to their
AI counterparts.
Those miRNAs, which are located within or nearby
imprinted regions of the chromosome, showed a clear
deregulation of their expression in NT and IVP ex-
panded blastocyst when compared to expanded AI blas-
tocysts. Collectively, the results of the present study
evidenced trophoblast specific and imprinted miRNAs
to be aberrantly expressed in NT blastocysts when com-
pared to miRNAs which are specific for the inner cell
mass or embryonic stem cells. Similarly, previous stud-
ies have reported changes in miRNA expression during
trophectoderm specification [21] and aberrant epigen-
etic reprogramming and thus expression of imprinted
miRNAs (e.g. miR-127, miR-136) in cloned mouse em-
bryos [13]. Therefore, a profound deregulation of miRNA
expression due to reprogramming failure is found to occur
around day 50 of NT pregnancies at which time complex
placentomes are developing. The deregulation of miRNAs
at the elongated stage could be attributed to the cell spe-
cific aberrant expression, but this could not be elucidated
as because, elongated embryos were comprised of embry-
onic and extra-embryonic tissues. However, at day 50 of
pregnancy differences with respect to miRNA expression
were significantly evident by down regulation of most of
them in NT placentas compared to AI counterparts. Inter-
estingly, the degree of miRNA deregulation at day 225 of
pregnancy either in NT or IVP compared to AI was found
to be very small, indicating temporal regulation of these
miRNAs in bovine placentas. At approximately day 50,
those fetuses with suboptimal placentome formation and
with more deregulated miRNA expression could be slowly
starved to death, whereas fetus that progress beyond this
stage have better placentome development as studied
previously [1].
Major causes for miRNA deregulation in NT and IVP
derived placentas
Major sources of aberrant gene expression in NT placentas
have been found to be due to abnormal epigenetic and gen-
etic processes. These include non-coding RNA mediated
regulation, aberrant DNA methylation, genomic imprinting
and chromatin remodeling. Maintenance of imprinting has
been shown to be less dependent on DNA methylation in
the placenta compared to the embryo itself, with involve-
ment of repressive histone methylation rather than DNA
methylation [9]. The present findings reveal that there is no
significant difference in global DNA methylation in elon-
gated day-16 embryos and day-50 placentas derived from
NT, IVP and AI. Therefore, it is possible to postulate thatother genetic or epigenetic processes including aberrant
regional chromatin remodeling rather than global DNA
methylation are responsible for massive deregulation of
miRNAs in the NT or IVP placentas.
Bioinformatic analysis of the deregulated miRNAs re-
vealed that miRNAs were mostly deregulated as cluster
and show similarities in their deregulation between the
members within the same miRNA family. They were found
to be transcribed in a large transcription units of coding or
non-coding genes using their own promoters as an inde-
pendent entities or as polycistrons [22]. Therefore, any
transcriptional or processing disturbance during the earlier
stage of cloned embryo and extra embryonic lineage
differentiation due to improper reprogramming of specific
regulatory molecules responsible for global transcription,
processing and maturation of miRNAs could be a potential
reason for global down regulation of miRNAs in NT or
IVP derived placentas. To elucidate these possibilities, we
profiled 18 well known miRNA processing machinery
genes in different placentas of different origins. Our results
indicate that several of such molecules were not proper
reprogrammed in NT or IVP derived placentas when com-
pared to that of AI derived placentas or donor fibroblast
cells. Among them, eukaryotic transcription initiation
factor 2C2 (EIF2C2) or AGO2 was found to be down
regulated in the NT and IVP placentas due to hyperme-
thylation of their promoter region compared to that pla-
centas derived from AI, which could be linked to down
regulation of miRNAs as reported previously [23,24].
Expression of AGO2 has been shown to be stable in
trophoblast [25] and important in many biological pro-
cesses and development including mouse oogenesis [26],
early development [27] and maternal-zygotic transition
[28]. Embryonic fibroblasts and hematopoietic cells from
AGO2 knockout mouse showed reduction of all mature
miRNAs [29,30]. Therefore, according to previous reports
and findings of this study, it is possible to speculate that
global down regulation of miRNAs in the NT and IVP de-
rived day-50 placentas compared to that of AI might be
due to deregulation of miRNA processing genes along
with aberrant reprogramming of other factors.
According to the results published so far on the role
of miRNAs in early mammalian development, it is clear
that earliest differentiation events leading to epiblast and
trophectoderm lineages proceed normally in the absence
of canonical miRNAs [31]. The present study however
shows that the second lineage differentiation is affected
by deregulation of miRNAs. It has been reported that
AGO2-mutant embryos show abnormalities in implanted
decidua and hypotrophic placentas including marked re-
duction in the thickness of the labyrinthine layer [32]. The
present study, however, adds many additional cellular and
morphological defects in the trophoblast differentiation
in vitro including reduced trophoblastic giant cells,
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of alkaline phosphatase.
Conclusion
The results of the present study revealed a massive deregu-
lation of miRNAs in bovine day-50 placentas derived from
transfer of cloned or in vitro produced bovine embryos.
Most of the miRNAs were found to be poorly repro-
grammed and to be affected as large chromosomal cluster
and miRNA families. These findings suggest that genome
wide aberrant expression of miRNAs due to reprogram-
ming failure of miRNA processing regulatory molecules
(namely: aberrant AGO2 expression), regional chromatin
remodeling affecting polycystronic miRNA expression and
imprinting problems in placentas of nuclear transfer de-
rived pregnancy, may result in abnormal regulation of
transcriptional activities leading to subsequent pregnancy
loss. Taken together, aberrant expression of transcriptional
regulatory miRNA molecules during redifferentiation for
placentogenesis leading to abnormal genetic and epigenetic
modification in the placentas from cloned conceptuses are
likely caused by re-programming failure as a consequence
of somatic cell nuclear transfer as well as environmental
conditions during in vitro culture. Being important gene
regulators, miRNAs could display an interesting avenue to
resolve numerous open questions in terms of regulatory
mechanisms involved in genetic and/or epigenetic aberra-
tions in placentas of SCNT or IVP pregnancies.
Methods
In vitro embryo production (IVP) and processing
of blastocysts
Bovine ovaries were collected from local abattoir and
cumulus-oocyte complexes (COCs) were aspirated from
2- to 8-mm-diameter follicles. COCs with multiple cu-
mulus layers including evenly granulated cytoplasm were
selected, matured and fertilized in vitro using the frozen
semen of one single bull and developing embryos were
subsequently cultured in vitro using a standard protocol.
At day 7 (blastocyst) and day 8 (fully expanded blasto-
cyst) of embryo culture, a total of 5–8 embryos (washed
in PBS) were freezed in liquid nitrogen. A total of 20
embryos were fixed in 4% parafomaldehyde overnight at
4°C for whole mount in situ hybridization. Additionally,
in vitro derived day-7 blastocysts (n = 20) were transferred
singly to the recipients to generate day-16, day-50 and day-
225 pregnancies (details of the procedure are described in
Additional file 1).
In vivo embryo collection and generation of control
pregnancies (artificial insemination)
Simmental heifers were synchronized by intra muscular in-
jection of cloprostenol (PGF2α, Estrumate; Essex Tierarznei,
Munich, Germany) twice within 11 days and subsequentlysuperovulation was performed by injection of FSH
(Stimufol, Ulg FMV, Belgium) starting at day 11 after
onset of estrus. Frozen–thawed semen was used to insem-
inate all heifers. The blastocysts were flushed out with
500 ml D-PBS at day 7.5 post inseminations. Only mor-
phologically good-quality early blastocyst and expended
blastocysts (5 embryos per pool in triplicate for both
stages) were snap frozen. Moreover, a total of 20 expanded
blastocysts were fixed as mentioned before for in situ
hybridization. Heifers (n = 15) synchronized with a single
dose of PGF2α followed by estrus check were artificially
inseminated 10 hours after standing estrus using frozen
semen of the same sire used for production of IVP em-
bryos. Pregnancies were terminated at days 16, 50 and 225
to collect elongated day-16 control embryos as well as
placenta tissues at day 50 (n = 3) and day 225 (n = 4) of
pregnancies. All animal were handled according to animal
protection law of Germany. Moreover, the experiments
conducted in this study are approved by the Animal Pro-
tection Chair of the University of Bonn.
Donor cell preparation and nuclear transfer
Preparation of donor cells, nuclear transfer and em-
bryos culture has been performed according to the
protocol described elsewhere with some modification
(Additional file 1) [33]. Triplicate (5 in each) of both
early and expanded blastocysts were frozen as de-
scribed above. Additionally, blastocysts derived from
NT were fixed for whole mount in situ hybridization
and a total of 30 blastocysts was transferred singly to
synchronized recipients (n = 30).
Recipient preparation and embryo transfer
Estrous synchronization and transfer of embryos to the
recipients has been carried out according to the previous
report [34]. Single NT (n = 30) and IVP (n = 20) derived
embryos that were of good or excellent quality (grades 1
or 2) were transferred into the uterine horn ipsilateral to
the corpus luteum of recipients, respectively (details in
the Additional file 1: supplementary methods).
Pregnancy monitoring and retrieval of
experimental material
Recipients were monitored for coming back to estrus at
day 21 to be considered as non-pregnant. Pregnancy
diagnosis was performed at days 28 and 42 of gestation
by transrectal ultrasonography and by rectal palpation
at day 42 and 56. Recipients being pregnant after trans-
fer of IVP or NT derived embryos as well as heifers being
pregnant after AI were slaughtered gradually at day 16
(IVP-N = 5, AI-N = 5, NT-N = 5), day 50 (IVP-N = 3,
AI-N = 3, NT-N = 3) and day 225 (IVP-N= 4, AI-N = 4,
NT-N= 4) of pregnancy. Elongated embryos at day 16, cho-
rioallantois with early cotyledons at day 50 and
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nancy were collected, washed twice in PBS and stored in
RNA later (Ambion Inc, TX, USA).Extraction and purification of small RNAs from placentas
Total RNAs from the three individual frozen placentas
(15 mg) of each group of pregnancy (IVP, NT and AI)
and fibroblast cells (4 × 106) were isolated using miR-
Neasy mini kit (QIAGEN GmbH, Hilden, Germany). Large
(>200 nt) and small RNAs (<200 nt) were separated using
RT2 qPCR-Grade miRNA isolation kit (SABioscienecs,
Frederick, MD, USA) according to manufacturer’s instruc-
tions. The quality and the concentration of the small and
large RNAs were assessed by NanoDrop 8000 spectropho-
tometer (NanoDrop, Wilmington, Delaware, USA).Genomic DNA, total RNA and protein extraction
Whole individual elongated embryos at day 16, placentas
at day 50 (15 mg) and placentomes at day 225 (15 mg)
of pregnancy from IVP, NT and AI (at least three of each)
were used for isolation of gDNA, total RNA and protein
using DNA/RNA/Protein purification kit (Norgen Biotek
corporation, Thorold, Canada) according to the methods
recommended by the manufacturer. In addition, 5 early
blastocysts and 5 expanded blastocysts (from each IVP,
NT and AI method) were also used to isolate total RNAs
using the same procedures. The quality and the concen-
tration were assessed by NanoDrop 8000 spectrophotom-
eter (NanoDrop, Wilmington, Delaware, USA).Large scale expression profiling of miRNAs by real-time
quantitative PCR
Total of 166 ng small RNAs from 3 placentas at day 50 de-
rived from every group of pregnancy (IVP, NT and AI) and
donor cells (in triplicate) were synthesized into first strand
cDNAs using RT2 miRNA first strand kit (SABiosciences).
Real time qPCR of miRNAs was performed using 384-well
miRNAs primed PCR plate (SABiosciences) comprised of
377 individual miRNAs (most of them are conserved in
human, mouse and bovine), 4 endogenous controls (U6,
Snord44, Snord47 and Snord48), 2 reverse transcription
controls and 2 positive PCR controls according to the
protocols provided by the manufacturer. The assays were
performed in ABI 7900 HT real time PCR system (Applied
Biosystems, Foster City, CA, USA) with sybr green tech-
nology (SABiosciences). Data were analysed by ΔΔCt
method and normalization was performed by geometric
mean of four endogenous controls through SAbioscien-
ces’s PCR array data analysis on-line web-based analysis
portal provided with t test. A fold regulation 2 or more
with the value of P less than/equal to 0.05 were consid-
ered as significant different expression.Whole mount blastocyst in situ hybridization of miRNAs
Whole mount in situ hybridization of miRNAs in the
in vitro blastocysts was performed as described elsewhere
[35]. At least three embryos were used for the hybridization
of each miRNA. According to the expression patterns miR-
NAs in IVP embryos, selected candidate trophoblast and
inner cell mass specific and imprinted miRNAs were local-
ized to the expanded AI and NT blastocysts. Embryos were
mounted individually with VectaShield containing DAPI
(Vector laboratories, Burlingame, CA) and analyzed by
confocal laser scanning microscope (CLSM LSM-510,
Carl Zeiss, Germany). Scramble negative controls probes
have been used to prove the specificity of hybridization of
miRNA probes.
Reverse transcription and SYBR green qPCR for
selected miRNAs
Expression of selected miRNAs has been examined in
blastocyst, expanded blastocyst, day-16 elongated em-
bryo, day-50 placenta and day-225 placentome (from AI,
IVP and SCNT). All the reagents and kits used for this
purpose were obtained from Exiqon (Exiqon, Vedbaek,
Denmark). A 36 ng total RNA from each sample was ap-
plied to synthesize first strand cDNA using Universal
cDNA synthesis kit. Real time qPCR was performed using
LNA™ PCR primer set for mir- 21, -24, -127-3p, -135b, -
299-5p, -302, -376a, -431, and mir-544a with universal RT
primers using SYBR Green master mix in ABI PRISM®
7000 sequence detection system (Applied Biosystems,
Foster City, CA, USA). Dilution of cDNA, preparation
of mix and thermal cycling condition was performed
as recommended by the manufacturer. Data were ana-
lyzed as mentioned before except, normalization was
performed using the mean Ct value of U6 RNA and
5S ribosomal RNA.
Reverse transcription and SYBR green qPCR for miRNA
processing genes
Important candidate genes involved in transcription, pro-
cessing and generating mature miRNAs were quantified in
day-50 placentas derived from IVP, AI and NT pregnancy
by qPCR (Additional file 1: supplementary methods). Re-
verse transcription of 600 ng total RNA from each sample
was performed using Superscript II Reverse Transcriptase
(Invitrogen, Carlsbad, CA) in combination with random
primers (Invitrogen, Carlsbad, CA) and oligo (DT)23
(Sigma). All primers utilized were designed and optimized
in order to ensure optimum reaction efficiencies both for
target and housekeeping reference genes (GAPDH,
Histone). Triplicate reactions were performed for each gene
by standard PCR protocol recommended for the instru-
ment. Data were normalized and subsequent analysis was
performed using ΔΔCt methods [36] and analyzed as men-
tioned before (details in the Additional file 1).
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Genomic DNA from the 3 elongated day-16 embryos and
3 day-50 placentas from each IVP, AI and SCNT preg-
nancy was used to quantify the global methylation status
using Methylamp Global DNA Methylation Quantifica-
tion Ultra kit (Epigentek, Brooklyn, NY) according to user
instruction. Briefly, 200 ng of genomic DNA from each
sample was immobilized to the strip well and methylated
fraction of DNA was recognized by 5-methylcytosine anti-
body. Color was developed and absorbance reading was
performed in ThermoMax microplate reader (Molecular
Devices, Sunnyvale, CA) at 450 nm and subsequent ana-
lysis was performed according to the user instruction
of Methylamp Global DNA Methylation Quantification
Ultra kit.
Bisulfite genomic sequencing
Putative promoter region of bovine AGO2/EIF2C2
(chromosome 14: 2372494–2373020, sense strand) 500
bases upstream to the first exon has been used to design
primers for the amplification of bisulfite converted DNA
using MethPrimer and Methyl Primer Express® Software
v1.0 (Applied biosystem, Foster City, CA). About 500 ng
genomic DNA was used for bisulfite conversion using
EZ DNA Methylation Kit (Zymo Research, Orange, CA)
according to manufacturers’ instruction. Each converted
DNA upon amplifying the putative promoter region of
AGO2 were purified using QIAquick PCR purification kit
(QIAGEN GmbH, Hilden, Germany) and then cloned
into the pGEM-T Easy vector (Promega, Mannheim,
Germany) and transform into E. Coli. A minimum of 10
different clones from every sample were randomly selected
and processed for sequencing with M13 primers using
CEQ8000 sequencer system (Beckman Coulter, Brea, CA).
Conversion efficiency and methylation sites were analyzed
by Quantification Tool for Methylation Analysis [37]
(details in Additional file 1).
Western blotting
Total proteins from 3 day-50 placentas from same group
(IVP, AI and SCNT) were pooled equally (30 μg) and
separated by SDS-PAGE (gradient 4-18%) and transferred
onto a nitrocellulose membrane (Amersham Biosciences).
Blocking was performed in buffer (20 mM Tris pH 7.5,
150 mM NaCl, 0.05% Tween-20 and 1% polyvinylpyroli-
done) at room temperature for 1 hour and then incubated
with goat anti-eIF2C2 polyclonal antibody (Santa Cruz
Biotechnology, Santa Cruz, CA) overnight at 4°C. The
membrane was incubated for 1 h at room temperature
with secondary antibody (HRP-conjugated mouse anti-
goat IgG). The chemiluminescence was detected using
ECL plus western blotting detection system (Amersham
Biosciences) and visualized by using Kodak BioMax XAR
film. The membrane was stripped by incubation in 2%SDS, 100 mM Tris–HCl and 0.1% beta-mercaptoethanol
for 30 min at 60°C and re-probed with GAPDH antibody
(loading control).
Derivation and culture of bovine TBSs
Bovine blastocysts were produced in vitro by the similar
method used for production of embryos which were trans-
ferred to the recipient cows for the generation of IVP
pregnancies as mentioned earlier. TBSs from in vitro pro-
duced blastocysts were derived according to the method
described elsewhere [38]. Briefly, on day 9, hatched blas-
tocysts were individually cultured onto collagen-coated
dishes in the uterine fibroblast conditioned medium
[Dulbecco’s modified Eagle’s/F-12 medium (Gibco)
containing 100 IU/ml penicillin and 100 μg/ml strepto-
mycin (Sigma), supplemented with 50% bovine uterine
fibroblast conditioned medium, 10% FBS, 50 μm β-
mercaptoethanol] at 37°C in an atmosphere of 5% CO2.
Blastocysts were found to be attached within a few days
having remarkable cell outgrowth and proliferation
(Figures 5A,B and C). The medium was changed every
2 or 3 days and mechanically passaged the confluent
cell sheets by pipetting, which were plated onto collagen-
coated 25-cm2 flasks (Figure 5D) and cultured till to be-
come confluent (Figure 5F). Cells were maintained for at
least 20 passages without any apparent changes in their
morphology and viability.
TBSs differentiation in vitro and AGO2 knock down
Established bovine trophoblastic cells were differentiated
in vitro on collagen substrata according to the method
developed earlier [39] with some modification. Briefly,
mechanically dissociated cell sheets at passage 18–20 (de-
noted as day 1) were to broken down into very small cell
clumps through vigorous pipetting using 1000 μl tips, were
plated onto collagen-mounted 25-cm2 flask in differenti-
ation medium [Dulbecco’s modified Eagle’s/F-12 medium
containing 100 IU/ml penicillin and 100 μg/ml strepto-
mycin (Sigma), supplemented with 10% FBS, 50 μm β-
mercaptoethanol] for differentiation. The medium was
changed 3 times during 12 day culture period in 3 days
interval, where amount of FBS was reduced by 3% from
the differentiation medium each time to reach 1% at the
end. Differentiation was confirmed by the presence of
four distinct terminal cells namely trophoblast giant
cells, spongiotrophoblast, glycogen cells, and syncytial
trophoblast like cells.
Two FlexiTube siRNAs for bovine AGO2 targeting two
different position of mRNA sequence CAGGTTCTGCAC
CACGAGTTA (accession no. NM_205794.1, 2039–2060)
and CCGAGGAGAGTTAACAGGGAA (accession no.
NM_205794.1, 206–227) with the modification of 3´
Alexa Fluor 488 were designed and synthesized at
20 nM by Qiagen (QIAGEN GmbH, Hilden, Germany).
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flask divided in to 3 where one for transfection of AGO2
siRNA, one for scrambled siRNA and third one for only
transfection reagents without any siRNAs as negative
control. Trophoblast cell (2 × 104 cells/ml) during culture
for differentiation on 2nd day were transfected with of
the siRNA duplex at a final concentration of 5 nM
using HiPerFect Transfection Reagent (QIAGEN GmbH,
Hilden, Germany) in 24-well plates (mounted with colla-
gen gel) according to the manufacturer’s instructions.
Cells were incubated with the complexes for 24 hours and
medium was changed by fresh differentiation media
having 7% FBS. Cells were transfected again with siR-
NAs transfection complex on day 5. Similar to siRNA, a
separate group of cells were transfected with non-
specific scrambled siRNAs and only transfection regents
for another group were performed. Cells were dissoci-
ated through standard trypsinization and washed three
times in cold PBS. All results represent experiments
conducted in triplicate at least two times. Similar to well
plate, three separate cultures and transfections of cell were
performed in CoverWell perfusion chambers (Science
Services GmbH, Muenchen, Germany, Cat# E70326-46)
attached with microscope slide which were mounted
with collagen gel exactly like flasks prepared prior to
differentiation culture. All the transfection resulted in
uptake of the siRNAs in more than 90% of the cells
as assessed by green fluorescein signal by light fluor-
escent microscope. Analyses of the effects of miRNAs
on cell development were performed 6–7 days after
transfections.
Characterization of transfected trophoblast cells and
immuno-histochemistry
Cells were dissociated through standard trypsinization
and washed three times in cold PBS. Triplicate samples
from each treatment in 24 well plates of first time ex-
periment were used to isolate large RNA to quantify the
expression of AGO2 mRNA, small RNA to quantify the
expression of selected miRNAs and proteins to analyze
the changes of AGO2 protein from the same cells ac-
cording to the method mentioned earlier in case of pla-
centas. Cells from parallel batch were used to analyze
proliferation and viability using standard trypan blue
staining followed by counting in heamocytometer under
light microscope. Cells knocked down of AGO2 and
differentiated in perfusion chambers were used for
immuno-histochemistry (for detection of AGO2 expres-
sion) together with detection of alkaline phosphatase ac-
tivity (APA), status of differentiation into terminal cells
and degree of endoreduplication in the same chamber
slide. For immuno-histochemistry, chamber slides were
first fixed in 4% paraformaldehyde at 4°C for 10 minutes
and washed 3 times in PBS. Refixation was carried outwith cold (−20°C) acetone for 5 minutes followed by 3
times washing in PBS and subsequent with PBS contain-
ing 1% BSA. After blocking the slides were incubated
with AGO2 polyclonal antibody in blocking solution
(1:100) overnight at 4°C followed by washing 3 times in
PBS and incubation with anti-goat donkey antibody con-
jugated with Alexa Fluor® 488 (Invitrogen, Carlsbad, CA)
(1:200) for 1 hour at room temperature. Slides were
washed 3 times in PBS and equilibrated in 1 M tris
pH 8.2 for 10 minutes and 2 drops of fast red solution
(Fast Red Substrate System, Cat# K0699, Dako, Glostrup,
Denmark) were added to each chamber for staining the
APA for 30 minutes at RT. Antibody diluent was used in
the experiment as negative control. After washing the
chambers 3 times in PBST, perfusion chamber were
released from the glass slide. Slides were mounted with
VectaShield containing DAPI (Vector laboratories, Burlin-
game, CA) and analyzed by confocal laser scanning
microscope (CLSM LSM-510, Carl Zeiss, Germany).
Green, Cy5 and DAPI filter was used to detect AGO2
expression, APA and nuclear status including endore-
duplication, respectively. Over 500 cells from at least 9
images were analyzed per experiment. Irrelevant IgG
was assessed to be negative.
Additional file
Additional file 1: Is available with the online version of this paper
which contains detailed experimental procedures, result of primary
analysis as graph (Figure S1, S2 and S3), a table (Table S1) listing
the primers and oligos used in the experiment.
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